Report #2896103

Received May 11, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 16 yrs
State: NC
Recovered: Unknown
Vaccinated: Apr 27, 2026
Onset: Apr 27, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	93YN2	—

Symptoms (1)

Incorrect dose administered

Symptom narrative

Adult dose of Havrix administered to a 16-yr old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult product administered to child in a 16-year-old female patient who received HAV (Havrix 1440 adult) (batch number 93YN2, expiry date 03-FEB-2028) for prophylaxis. On 27-APR-2026, the patient received Havrix 1440 adult 1 ml. On 27-APR-2026, an unknown time after receiving Havrix 1440 adult, the patient experienced adult product administered to child (Verbatim: Adult dose of Havrix administered to a 16-yr old patient). The outcome of the adult product administered to child was not applicable. Additional Information: GSK Receipt Date: 28-APR-2026 A pharmacist reported that a 16-year-old patient received an adult dose of Havrix.